医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2009年
7期
1215-1217
,共3页
心肌梗塞%心肌再灌注%心室功能, 左%预后
心肌梗塞%心肌再灌註%心室功能, 左%預後
심기경새%심기재관주%심실공능, 좌%예후
myocardial infarction%myocardial reperfusion%ventricular function,left%prognosis
[目的]探讨心肌灌注指数联合左室舒张功能指标预测急性前壁心肌梗死(AMI)患者预后的价值.[方法]54例急性前壁心肌梗死患者根据急诊经皮冠脉介入治疗后心肌灌注情况和左室舒张功能分为三组.A组:心肌灌注及左室舒张功能正常,B组:心肌灌注异常或左室舒张功能异常,C组:心肌灌注及左室舒张功能均异常.追踪患者出院后3年内情况,分析其与心肌灌注和左室舒张功能的关系.[结果]A组患者预后最佳,3年存活率为84.2%,C组患者预后最差,3年存活率为53.3%,B组为75.0%.[结论]心肌灌注联合左室舒张功能可以用于预测急性前壁心肌梗死患者预后,及早发现高危患者,有利于临床治疗.
[目的]探討心肌灌註指數聯閤左室舒張功能指標預測急性前壁心肌梗死(AMI)患者預後的價值.[方法]54例急性前壁心肌梗死患者根據急診經皮冠脈介入治療後心肌灌註情況和左室舒張功能分為三組.A組:心肌灌註及左室舒張功能正常,B組:心肌灌註異常或左室舒張功能異常,C組:心肌灌註及左室舒張功能均異常.追蹤患者齣院後3年內情況,分析其與心肌灌註和左室舒張功能的關繫.[結果]A組患者預後最佳,3年存活率為84.2%,C組患者預後最差,3年存活率為53.3%,B組為75.0%.[結論]心肌灌註聯閤左室舒張功能可以用于預測急性前壁心肌梗死患者預後,及早髮現高危患者,有利于臨床治療.
[목적]탐토심기관주지수연합좌실서장공능지표예측급성전벽심기경사(AMI)환자예후적개치.[방법]54례급성전벽심기경사환자근거급진경피관맥개입치료후심기관주정황화좌실서장공능분위삼조.A조:심기관주급좌실서장공능정상,B조:심기관주이상혹좌실서장공능이상,C조:심기관주급좌실서장공능균이상.추종환자출원후3년내정황,분석기여심기관주화좌실서장공능적관계.[결과]A조환자예후최가,3년존활솔위84.2%,C조환자예후최차,3년존활솔위53.3%,B조위75.0%.[결론]심기관주연합좌실서장공능가이용우예측급성전벽심기경사환자예후,급조발현고위환자,유리우림상치료.
[Objective]To evaluate the value of myocardial perfusion combined with left ventricular diastolic function for predicting the prognosis of acute anterior wall myocardial infarction (AMI). [Methods]Fifty four anterior wall AMI patients were enrolled. Myocardial perfusion combined with left ventricular diastolic function was evaluated by coronary angiography and echocardiography, respectively. Patients were divided into 3 groups based on myocardial perfusion and diastolic function: Group A (normal perfusion and normal diastolic function), Group B (abnormal perfusion or abnormal diastolic function) and Group C (abnormal perfusion and abnormal diastolic function). The long term all-cause mortality was compared within three groups. [Results] Survival rate was much higher in Group A (84.2%), and lowest in group C (53.3%). [Conclusion] Myocardial perfusion combined with left ventricular diastolic function is useful for predicting the prognosis of anterior wall AMI and has the benefit for the early diagnosis and treatment of high-risk patients.